(360 days)
No
The device description and intended use focus on the physical characteristics and basic electrical functions of a catheter, with no mention of AI, ML, or data processing beyond standard electrical signal acquisition.
No
The device is described as providing "diagnostic information" and its intended uses are for "electrophysiology studies," "intra-cardiac ECG," and "electrical stimulation," all of which are diagnostic procedures, not therapeutic ones.
Yes
The "Intended Use / Indications for Use" section explicitly states that the device is "designed to provide diagnostic information" and lists "Intra-cardiac ECG" as one of its uses, which is a diagnostic procedure.
No
The device description clearly details physical components like electrodes, a balloon, a catheter shaft, and a manifold, indicating it is a hardware device.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In Vitro Diagnostics are medical devices used to perform tests on samples taken from the human body (like blood, urine, tissue) to provide information about a person's health. These tests are performed outside the body.
- Device Function: The Hexapolar Electrode Balloon Floatation Catheter is designed for intracardiac use. It is inserted directly into the heart to perform diagnostic procedures like recording electrical activity and electrical stimulation. This is an in vivo (within the living body) procedure, not an in vitro procedure.
- Intended Use: The stated intended uses (electrophysiology studies, intra-cardiac ECG, electrical stimulation) are all procedures performed directly on the patient's heart, not on samples taken from the patient.
Therefore, while the device provides diagnostic information, it does so through direct interaction with the patient's body, which is the defining characteristic of an in vivo diagnostic device, not an in vitro diagnostic device.
N/A
Intended Use / Indications for Use
The Hexapolar Electrode Balloon Floatation Catheter is designed to provide diagnostic information. It is intended to be used for the following:
-
- Temporary use in electrophysiology studies;
-
- Intra-cardiac ECG; and
-
- Electrical stimulation.
Product codes
74 DRF
Device Description
The Hexapolar Electrode Balloon Flotation Catheter (HEBFC) is furnished in both five and seven French sizes.
The device has an electrode mounted at the distal tip with a latex balloon proximal to the tip electrode. There are five electrodes mounted on the shaft proximal to the balloon. The shaft has bands every ten centimeters. At the manifold, the extension with a Stopcock is connected to the Air Lumen. The electrode wire areconnected to wire extensions with pin connectors. These are coded with numbers for identification.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Intracardiac
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
The performance data such as mechanical strengths and electrical tests remain the same as with the Predicate Device.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 870.1220 Electrode recording catheter or electrode recording probe.
(a)
Identification. An electrode recording catheter or an electrode recording probe is a device used to detect an intracardiac electrocardiogram, or to detect cardiac output or left-to-right heart shunts. The device may be unipolar or multipolar for electrocardiogram detection, or may be a platinum-tipped catheter which senses the presence of a special indicator for cardiac output or left-to-right heart shunt determinations.(b)
Classification. Class II (performance standards).
0
KG71504
Image /page/0/Picture/1 description: The image shows the logo for J-LLOYD MEDICAL INC. The logo features a stylized sunburst graphic to the left of the text. The text is in bold, sans-serif font and is all capitalized.
ommerce Lane, Suite 6, 1. New Jersey 08009, U.S.A.
APR 20 1998
510 K SUMMARY (as required by 807.92 c)
Date: April 15, 1997
Telephone 609-753-8339
Fax 609-753-8340
Submitter: James L. Skaggs, Sr. 415 Commerce Lane, Suite 6 Berlin, New Jersey 08009 Phone: 609-753-8339 609-753-8340 FAX:
Contact Person: Same as above.
Product: Hexapolar Electrode Balloon Flotation Catheter
I. Predicate Device:
The J-LLoyd Medical, Inc. Bipolar Balloon Pacing Catheter has been approved by FDA 510K #K930069. The function of this device is to provide emergency, temporary pacing.
II. Description of New Device:
The Hexapolar Electrode Balloon Flotation Catheter (HEBFC) is furnished in both five and seven French sizes.
The device has an electrode mounted at the distal tip with a latex balloon proximal to the tip electrode. There are five electrodes mounted on the shaft proximal to the balloon. The shaft has bands every ten centimeters. At the manifold, the extension with a Stopcock is connected to the Air Lumen. The electrode wire are connected to wire extensions with pin connectors. These ದಿನ ನಾಗಿ ಸ್ಥ are coded with numbers for identification. 2 2017 11:11
III. Intended Use of New Device:
The Hexapolar Electrode Balloon Flotation Catheter is designed for use as follows:
-
- Temporary use in electrophysiology studies
-
Intracardiac ECG recording
-
Electrical Stimulation.
1
LOYD MEDICAL INC.
Immerce Lane, Suite 6, New Jersey 08009, U.S.A Telephone 609-753-8339 Fax 609-753-8340
IV. Technological Characteristics of New Device and Predicate Device (510K #K930069)
-
The Hexapolar Electrode Balloon Flotation Catheter and the Predicate Catheter are basically the same, using the same materials, the same basic design and the same methods of assembly.
-
The difference is the addition of four electrodes to the Predicate Device which has two electrodes. The addition of the four electrodes increases the functions from just electrical stimulation to also include temporary use in electrophysiology studies and intracardiac ECG recording.
-
The performance data such as mechanical strengths and electrical tests remain the same as with the Predicate Device.
-
The Biological, Chemical, and Sterilization specifications remain the same as the Predicate Device, in that the only physical difference is the addition of materials (electrodes) presently used on the Predicate Device.
V. Safety Statement:
-
As with any invasive procedure, there are certain inherent hazards, however, these hazards have been identified in the instruction sheet under the titles of Precautions and Warnings. It is important that the physicians be aware of the basic principles involved prior to using these devices in their varied application.
-
Based on engineering the J-LLoyd Medical. Inc. devices and the fact that the basic design has been in use since before May 28, 1976, by thousands of physicians, in hundreds of hospitals world wide, it is our judgement that this device presents an acceptable level of safety when properly used by a trained physician.
James L. Shepard.
James L. Skaggs, Jr. General Manager
2
Image /page/2/Picture/1 description: The image shows the seal of the Department of Health & Human Services (HHS). The seal features a stylized eagle with three profiles facing right, representing the department's mission to protect the health of all Americans and provide essential human services. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular pattern around the eagle.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
APR 20 1330
Mr. James L. Skaggs, Sr. General Manager J-Lloyd Medical, Inc. 415 Commerce Lane, Suite 6 Berlin, New Jersey 08009
K971504 Re: Hexapolar Electrode Balloon Flotation Catheter Requlatory Class: II (two) Product Code: 74 DRF February 5, 1998 Dated: Received: February 6, 1998
Dear Mr. Skaggs:
We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major requlations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 A substantially equivalent determination assumes compliance to 895. with the Current Good Manufacturing Practice requirements, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic QS inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.
3
This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4648. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its internet address "http://www.fda.gov/cdrh/dsmamain.html".
Sincerely yours,
Thomas J. Callahan
Thomas J. Callahan, Ph.D. ....... Director Division of Cardiovascular, Respiratory, and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
Page 1 of 1
510(k) Number (if known): K971504
Device Name: Hexapolar Electrode Balloon Floatation Catheter
Indications For Use:
The Hexapolar Electrode Balloon Floatation Catheter is designed to provide diagnostic information. It is intended to be used for the following:
-
- Temporary use in electrophysiology studies;
-
- Intra-cardiac ECG; and
-
- Electrical stimulation.
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Obertk Tule
(Division Sign-Off) Division of Cardiovascular, Respiratory, and Neurological Devices 510(k) Number_
Prescription Use X (Per 21 CFR 801.109)
OR
Over-The-Counter Use